The tubarial glands paper: A starting point. A reply to comments

Affiliations

¹ Dept. of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute (NCI), Amsterdam, The Netherlands; Dept. of Oral and Maxillofacial Surgery, Amsterdam UMC (AUMC), University of Amsterdam, Amsterdam, The Netherlands. Electronic address: m.valstar@nki.nl.
² Dept. of Medical Biology, Section Clinical Anatomy & Embryology, AUMC, University of Amsterdam, Amsterdam, The Netherlands.
³ Dept. of Radiation Oncology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
⁴ Dept. of Pathology, NCI, Amsterdam, The Netherlands.
⁵ Dept. of Head and Neck Surgical Oncology, UMC Utrecht Cancer Center (UMCU), University Medical Center Utrecht, Utrecht, The Netherlands; Dept. of Oral and Maxillofacial Surgery, UMCU, Utrecht, The Netherlands.
⁶ Core Facility Molecular Pathology & Biobanking, Division of Pathology, NCI, Amsterdam, The Netherlands.
⁷ Dept. of Radiology and Nuclear Medicine, UMCU, Utrecht, The Netherlands.
⁸ Dept. of Radiology, Amsterdam UMC (AUMC), Amsterdam, The Netherlands.
⁹ Dept. of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute (NCI), Amsterdam, The Netherlands; Dept. of Oral and Maxillofacial Surgery, Amsterdam UMC (AUMC), University of Amsterdam, Amsterdam, The Netherlands.
¹⁰ Dept. of Nuclear Medicine, NCI, Amsterdam, The Netherlands; Dept. of Radiation Oncology, NCI, Amsterdam, The Netherlands.

PMID: 33310008
DOI: 10.1016/j.radonc.2020.12.001

Comment

The tubarial glands paper: A starting point. A reply to comments

Matthijs H Valstar et al. Radiother Oncol. 2021 Jan.

. 2021 Jan:154:308-311.

doi: 10.1016/j.radonc.2020.12.001. Epub 2020 Dec 11.

Authors

Affiliations

¹ Dept. of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute (NCI), Amsterdam, The Netherlands; Dept. of Oral and Maxillofacial Surgery, Amsterdam UMC (AUMC), University of Amsterdam, Amsterdam, The Netherlands. Electronic address: m.valstar@nki.nl.
² Dept. of Medical Biology, Section Clinical Anatomy & Embryology, AUMC, University of Amsterdam, Amsterdam, The Netherlands.
³ Dept. of Radiation Oncology, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
⁴ Dept. of Pathology, NCI, Amsterdam, The Netherlands.
⁵ Dept. of Head and Neck Surgical Oncology, UMC Utrecht Cancer Center (UMCU), University Medical Center Utrecht, Utrecht, The Netherlands; Dept. of Oral and Maxillofacial Surgery, UMCU, Utrecht, The Netherlands.
⁶ Core Facility Molecular Pathology & Biobanking, Division of Pathology, NCI, Amsterdam, The Netherlands.
⁷ Dept. of Radiology and Nuclear Medicine, UMCU, Utrecht, The Netherlands.
⁸ Dept. of Radiology, Amsterdam UMC (AUMC), Amsterdam, The Netherlands.
⁹ Dept. of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute (NCI), Amsterdam, The Netherlands; Dept. of Oral and Maxillofacial Surgery, Amsterdam UMC (AUMC), University of Amsterdam, Amsterdam, The Netherlands.
¹⁰ Dept. of Nuclear Medicine, NCI, Amsterdam, The Netherlands; Dept. of Radiation Oncology, NCI, Amsterdam, The Netherlands.

PMID: 33310008
DOI: 10.1016/j.radonc.2020.12.001

No abstract available

Keywords: Head and neck cancer; PSMA PET/CT; Radiation toxicity; Radiotherapy; Salivary glands; Tubarial glands.

PubMed Disclaimer

Comment on

The tubarial salivary glands: A potential new organ at risk for radiotherapy.
Valstar MH, de Bakker BS, Steenbakkers RJHM, de Jong KH, Smit LA, Klein Nulent TJW, van Es RJJ, Hofland I, de Keizer B, Jasperse B, Balm AJM, van der Schaaf A, Langendijk JA, Smeele LE, Vogel WV. Valstar MH, et al. Radiother Oncol. 2021 Jan;154:292-298. doi: 10.1016/j.radonc.2020.09.034. Epub 2020 Sep 23. Radiother Oncol. 2021. PMID: 32976871
Letter to the editor concerning Valstar et al., [Radiother Oncol 2020 Sep 23;S0167-8140(20)30809-4. doi: 10.1016/j.radonc.2020.09.034].
Bikker FJ, Vissink A. Bikker FJ, et al. Radiother Oncol. 2021 Jan;154:318. doi: 10.1016/j.radonc.2020.12.005. Epub 2020 Dec 10. Radiother Oncol. 2021. PMID: 33309998 No abstract available.
Letter to the Editor regarding "The tubarial salivary glands: A potential new organ at risk for radiotherapy".
Nascimento JJC, Ribeiro ECO, Silva-Neto EJ. Nascimento JJC, et al. Radiother Oncol. 2021 Jan;154:323. doi: 10.1016/j.radonc.2020.12.014. Epub 2020 Dec 11. Radiother Oncol. 2021. PMID: 33310000 No abstract available.
Clinical implications of tubarial salivary glands.
Thakar A, Kumar R, Thankaraj AS, Rajeshwari M, Sakthivel P. Thakar A, et al. Radiother Oncol. 2021 Jan;154:319-320. doi: 10.1016/j.radonc.2020.12.006. Epub 2020 Dec 11. Radiother Oncol. 2021. PMID: 33310001 No abstract available.
RE: Valstar et al., "The tubarial salivary glands: A potential new organ at risk for radiotherapy".
Ellsworth SG, Winkfield KM, Greenberger JS. Ellsworth SG, et al. Radiother Oncol. 2021 Jan;154:312-313. doi: 10.1016/j.radonc.2020.12.002. Epub 2020 Dec 11. Radiother Oncol. 2021. PMID: 33310002 No abstract available.
Comments on "The tubarial salivary glands: First description of a potential new organ at risk for head-neck radiotherapy".
Cohen Goldemberg D, Novaes Pinheiro T, Santos-Silva AR, de Melo AC, Leão JC, Fedele S, Porter S. Cohen Goldemberg D, et al. Radiother Oncol. 2021 Jan;154:316-317. doi: 10.1016/j.radonc.2020.12.004. Epub 2020 Dec 11. Radiother Oncol. 2021. PMID: 33310003 No abstract available.
Are "tubarial salivary glands" a previously unknown structure?
Mudry A, Jackler RK. Mudry A, et al. Radiother Oncol. 2021 Jan;154:314-315. doi: 10.1016/j.radonc.2020.12.003. Epub 2020 Dec 11. Radiother Oncol. 2021. PMID: 33310006 No abstract available.
No convincing evidence for the presence of tubarial salivary glands: A letter to the editor regarding "The tubarial salivary glands: A potential new organ at risk for radiotherapy".
Iwanaga J, Ibaragi S, Nakano K, Takeshita Y, Tubbs RS. Iwanaga J, et al. Radiother Oncol. 2021 Jan;154:321-322. doi: 10.1016/j.radonc.2020.12.007. Epub 2020 Dec 11. Radiother Oncol. 2021. PMID: 33310009 No abstract available.
A macroscopic salivary gland and a potential organ or simply tubarial sero-mucinous glands?
Narayan RK, Kumari C, Panchal P, Ghosh SK, Kumar A. Narayan RK, et al. Radiother Oncol. 2021 Jan;154:324-325. doi: 10.1016/j.radonc.2020.12.016. Epub 2020 Dec 24. Radiother Oncol. 2021. PMID: 33347865 No abstract available.
Salivary glands at the pharyngeal ostium of the Eustachian tube are already described in histological literature.
Schumann S. Schumann S. Radiother Oncol. 2021 Jan;154:326. doi: 10.1016/j.radonc.2020.12.022. Epub 2020 Dec 30. Radiother Oncol. 2021. PMID: 33387583 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The tubarial glands paper: A starting point. A reply to comments

Affiliations

The tubarial glands paper: A starting point. A reply to comments

Authors

Affiliations

Comment on

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Miscellaneous